Literature DB >> 15717026

Huntington's disease genetics.

Richard H Myers1.   

Abstract

Huntington's disease (HD) is a dominantly transmitted neurodegenerative disorder with wide variation in onset age but with an average age at onset of 40 years. Children of HD gene carriers have a 50% chance of inheriting the disease. The characteristic symptoms of HD are involuntary choreiform movements, cognitive impairment, mood disorders, and behavioral changes which are chronic and progressive over the course of the illness. HD is a "trinucleotide repeat" disorder, which is caused by an increase in the number of CAG repeats in the HD gene. Repeats of 40 or larger are associated with disease expression, whereas repeats of 26 and smaller are normal. Intermediate numbers of repeats, between 27 and 35, are not associated with disease expression but may expand in paternal transmission, resulting in the disease in descendents. Repeats of 36-39 are associated with reduced penetrance whereby some develop HD and others do not. The identification of the genetic defect in HD permits direct genetic testing for the presence of the gene alteration responsible for the disease. Tests may be performed in three circumstances: (1) confirmation of diagnosis, (2) predictive testing of persons at genetic risk for inheriting HD, and (3) prenatal testing. Testing is widely available and much experience has been gained with protocols that assist the individual in making an informed choice about test options, and minimize the occurrence of adverse emotional outcomes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15717026      PMCID: PMC534940          DOI: 10.1602/neurorx.1.2.255

Source DB:  PubMed          Journal:  NeuroRx        ISSN: 1545-5343


  25 in total

1.  New problems in testing for Huntington's disease: the issue of intermediate and reduced penetrance alleles.

Authors:  A Maat-Kievit; M Losekoot; H Van Den Boer-Van Den Berg; G J Van Ommen; M Niermeijer; M Breuning; A Tibben
Journal:  J Med Genet       Date:  2001-04       Impact factor: 6.318

2.  Anonymous predictive testing for Huntington's disease in the United States.

Authors:  C L Visintainer; V Matthias-Hagen; M A Nance
Journal:  Genet Test       Date:  2001

Review 3.  Preimplantation genetic diagnosis.

Authors:  The-Hung Bui; Joyce C Harper
Journal:  Clin Obstet Gynecol       Date:  2002-09       Impact factor: 2.190

Review 4.  Huntingtin aggregation and toxicity in Huntington's disease.

Authors:  Gillian Bates
Journal:  Lancet       Date:  2003-05-10       Impact factor: 79.321

5.  A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.

Authors:  E W Almqvist; M Bloch; R Brinkman; D Craufurd; M R Hayden
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

6.  High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia.

Authors:  E W Almqvist; D S Elterman; P M MacLeod; M R Hayden
Journal:  Clin Genet       Date:  2001-09       Impact factor: 4.438

Review 7.  Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders.

Authors:  Christopher A Ross
Journal:  Neuron       Date:  2002-08-29       Impact factor: 17.173

8.  Non-disclosing preimplantation genetic diagnosis for Huntington disease.

Authors:  Harvey J Stern; Gary L Harton; Michael E Sisson; Shirley L Jones; Lee A Fallon; Lilli P Thorsell; Michael E Getlinger; Susan H Black; Joseph D Schulman
Journal:  Prenat Diagn       Date:  2002-06       Impact factor: 3.050

9.  Strategies and outcomes of the first 100 cycles of preimplantation genetic diagnosis at the Guy's and St. Thomas' Center.

Authors:  Susan Pickering; Nikolaos Polidoropoulos; Jenny Caller; Paul Scriven; Caroline Mackie Ogilvie; Peter Braude
Journal:  Fertil Steril       Date:  2003-01       Impact factor: 7.329

Review 10.  Coenzyme Q10 as a possible treatment for neurodegenerative diseases.

Authors:  M Flint Beal
Journal:  Free Radic Res       Date:  2002-04
View more
  89 in total

1.  Episodic memory in dementia: Characteristics of new learning that differentiate Alzheimer's, Huntington's, and Parkinson's diseases.

Authors:  Eleni Aretouli; Jason Brandt
Journal:  Arch Clin Neuropsychol       Date:  2010-06-08       Impact factor: 2.813

2.  Genetic tests: between risks and opportunities. The case of neurodegenerative diseases.

Authors:  Donato Ramani; Chiara Saviane
Journal:  EMBO Rep       Date:  2010-11-19       Impact factor: 8.807

Review 3.  Why tell asymptomatic children of the risk of an adult-onset disease in the family but not test them for it?

Authors:  P J Malpas
Journal:  J Med Ethics       Date:  2006-11       Impact factor: 2.903

Review 4.  Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?

Authors:  H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Nathanael Hevelone; Steven M Hersch
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

5.  Genetics of Huntington disease.

Authors:  S Mahalingam; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-14       Impact factor: 3.825

Review 6.  Stem Cells Transplantation and Huntington's Disease.

Authors:  Wooseok Im; Soon-Tae Lee; Kon Chu; Manho Kim; Jae-Kyu Roh
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

7.  Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem.

Authors:  Udo Rüb; Matthias Hentschel; Katharina Stratmann; Ewout Brunt; Helmut Heinsen; Kay Seidel; Mohamed Bouzrou; Georg Auburger; Henry Paulson; Jean-Paul Vonsattel; Herwig Lange; Horst-Werner Korf; Wilfred den Dunnen
Journal:  Brain Pathol       Date:  2014-03-03       Impact factor: 6.508

8.  Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : a cross-sectional study.

Authors:  N Klepac; M Relja; R Klepac; S Hećimović; T Babić; V Trkulja
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

9.  Clinical and genetic data of Huntington disease in Moroccan patients.

Authors:  Ahmed Bouhouche; Wafaa Regragui; Hind Lamghari; Khadija Khaldi; Nazha Birouk; Safaa Lytim; Soufiane Bellamine; Yamna Kriouile; Naima Bouslam; El Hachmia Ait Ben Haddou; Mustapha Alaoui Faris; Ali Benomar; Mohamed Yahyaoui
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

10.  Study of plasma-derived miRNAs mimic differences in Huntington's disease brain.

Authors:  Andrew G Hoss; Valentina N Lagomarsino; Samuel Frank; Tiffany C Hadzi; Richard H Myers; Jeanne C Latourelle
Journal:  Mov Disord       Date:  2015-11-17       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.